![Thomas Schall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Schall
Président chez
IMMUNEERING CORPORATION
Fortune : 430 038 $ au 31/05/2026
Profil
Dr. Thomas J.
Schall is a Chairman at Immuneering Corp.
Dr. Schall was previously employed as a Chairman, President & Chief Executive Officer by ChemoCentryx, Inc., a Principal by DNAX Research Institute of Molecular & Cellular Biology, Inc., and a Scientist by Genentech, Inc. He received his undergraduate degree from Northern Illinois University and a doctorate degree from Stanford University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/06/2026 | 74 530 ( 0,12 % ) | 430 038 $ | 31/05/2026 |
Postes actifs de Thomas Schall
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNEERING CORPORATION | Président | 16/09/2025 |
Anciens postes connus de Thomas Schall
| Sociétés | Poste | Fin |
|---|---|---|
| CHEMOCENTRYX, INC. | Directeur Général | 20/10/2022 |
DNAX Research, Inc. | Corporate Officer/Principal | 01/01/1997 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Directeur Technique/Scientifique/R&D | - |
Formation de Thomas Schall
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
30
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northern Illinois University
 Northern Illinois University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DNAX Research, Inc. | |
Immuneering Corp.
 Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
